Search

You searched for "impairment"

1996 results found

In conversation with Andrena McElvanney (President, MCLOSA)

22 September 2022 | EYE - Cornea
We spoke to Andrena about MCLOSA's annual meeting this November, key developments in cornea and external eye disease, and plans for the association’s 30th anniversary. Andrena McElvanney (top, second from right) and the OSI council members. The Medical Contact Lens...

Back-to-back congresses in Africa highlight international collaboration to advance eye health

4 December 2023 | | EYE - General
The ISOO Africa 2023 Congress The first International Society of Ocular Oncology (ISOO) [1] conference to be held in Africa took place in Mombasa, Kenya, from 21-23 August 2023. Participants came from all over Africa, as well as the US,...

Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk

7 December 2022 | | EYE - General, EYE - Cornea, EYE - Cataract, EYE - Glaucoma
It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...

My Top Five: Foundation year 3 jobs for prospective ophthalmology candidates

3 February 2023 | | EYE - General
Ophthalmology specialist training (OST) is a fantastic career option, however, it is also a highly competitive specialty. There was a gradual rise in competition ratios in recent years: 3.24 (2019), 5.73 (2020), and 6.80 (2021) [1]. Many choose to pursue...

My Top Five: Foundation year 3 jobs for prospective ophthalmology candidates

3 February 2023 | | EYE - General
Ophthalmology specialist training (OST) is a fantastic career option, however, it is also a highly competitive specialty. There was a gradual rise in competition ratios in recent years: 3.24 (2019), 5.73 (2020), and 6.80 (2021) [1]. Many choose to pursue...

Management of squint with near-distance angle disparity

5 February 2020 | | EYE - Cataract, EYE - Refractive, EYE - General
These are a group of strabismus disorders where the angle of misalignment is different between near and distance. The focus of this article will be on the patients where the angle for near exceeds the distance angle by more than...

Poppers retinopathy: What is it and how do we treat it?

2 June 2025 | | EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...

The results of the last survey Feb 2020

5 February 2020 | | EYE - Cataract, EYE - Refractive, EYE - General
I appreciate that I keep on reiterating it, but again we see so much practice variance. Who is right and who is wrong? Is there a right or wrong approach? And does it matter? I think it probably does matter....

Imaging papilloedema vs. pseudo-papilloedema

4 August 2021 | | EYE - Imaging, EYE - General
Quite often, in the working week as an ophthalmic photographer, you will be given that patient with ‘swollen discs’ to image. These swollen discs could be a number of things, but mainly fall into one of two categories: papilloedema or...

The treachery of images – making sense of OCT imaging

1 June 2016 | | EYE - Vitreo-Retinal, EYE - Imaging
In 1929 Belgian surrealist Rene Magritte produced his painting La Trahison des Images. It depicted an old fashioned pipe for smoking tobacco and underneath were the words “ceci n’est pas une pipe”, this is not a pipe. You may wonder...

Grading of ocular inflammation in uveitis: an overview

1 February 2016 | | EYE - Vitreo-Retinal
Anterior uveitis is the commonest form of uveitis, which can lead to severe morbidity if not treated appropriately [1]. Data from general ophthalmology practices suggest around 90% of uveitis encountered by comprehensive ophthalmologists is anterior uveitis [2]. Intermediate (vitreous), posterior...

Corporate M&A pace gathers momentum

1 October 2019 | | EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...